Glen Harbor Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $7.77M | Buy |
153,120
+47,584
| +45% | +$2.41M | 0.16% | 127 |
|
|
2019
Q2 | $4.79M | Buy |
105,536
+79,392
| +304% | +$3.6M | 0.1% | 196 |
|
|
2019
Q1 | $1.25M | Buy |
26,144
+10,816
| +71% | +$516K | 0.03% | 418 |
|
|
2018
Q4 | $797K | Sell |
15,328
-2,144
| -12% | -$111K | 0.02% | 480 |
|
|
2018
Q3 | $1.09M | Sell |
17,472
-272
| -2% | -$16.9K | 0.02% | 454 |
|
|
2018
Q2 | $982K | Sell |
17,744
-3,408
| -16% | -$189K | 0.02% | 441 |
|
|
2018
Q1 | $1.34M | Buy |
21,152
+3,408
| +19% | +$216K | 0.03% | 356 |
|
|
2017
Q4 | $1.09M | Buy |
17,744
+8,272
| +87% | +$507K | 0.02% | 412 |
|
|
2017
Q3 | $604K | Buy |
+9,472
| New | +$604K | 0.01% | 539 |
|
|
2017
Q1 | – | Sell |
-10,176
| Closed | -$595K | – | 1272 |
|
|
2016
Q4 | $595K | Buy |
+10,176
| New | +$595K | 0.02% | 460 |
|